The Effect of N-Acetyl-Aspartyl-Glutamate and N-Acetyl-Aspartate on White Matter Oligodendrocytes
Total Page:16
File Type:pdf, Size:1020Kb
doi:10.1093/brain/awp087 Brain 2009: 132; 1496–1508 | 1496 BRAIN A JOURNAL OF NEUROLOGY The effect of N-acetyl-aspartyl-glutamate and N-acetyl-aspartate on white matter oligodendrocytes Karolina Kolodziejczyk,1 Nicola B. Hamilton,1 Anna Wade,1 Ragnhildur Ka´rado´ ttir2 and David Attwell1 1 Department of Physiology, University College London, London, UK 2 Department of Veterinary Medicine, University of Cambridge, Cambridge, UK Correspondence to: David Attwell, Department of Physiology, University College London, Gower Street, London, WC1E 6BT, UK E-mail: [email protected] Elevations of the levels of N-acetyl-aspartyl-glutamate (NAAG) and N-acetyl-aspartate (NAA) are associated with myelin loss in the leucodystrophies Canavan’s disease and Pelizaeus-Merzbacher-like disease. NAAG and NAA can activate and antagonize neuronal N-methyl-D-aspartate (NMDA) receptors, and also act on group II metabotropic glutamate receptors. Oligodendrocytes and their precursors have recently been shown to express NMDA receptors, and activation of these receptors in ischaemia leads to the death of oligodendrocyte precursors and the loss of myelin. This raises the possibility that the failure to develop myelin, or demyelination, occurring in the leucodystrophies could reflect an action of NAAG or NAA on oligodendrocyte NMDA receptors. However, since the putative subunit composition of NMDA receptors on oligodendrocytes differs from that of neuronal NMDA receptors, the effects of NAAG and NAA on them are unknown. We show that NAAG, but not NAA, evokes an inward membrane current in cerebellar white matter oligodendrocytes, which is reduced by NMDA receptor block (but not by block of metabotropic glutamate receptors). The size of the current evoked by NAAG, relative to that evoked by NMDA, was 2+ much smaller in oligodendrocytes than in neurons, and NAAG induced a rise in [Ca ]i in neurons but not in oligodendrocytes. These differences in the effect of NAAG on oligodendrocytes and neurons may reflect the aforementioned difference in receptor subunit composition. In addition, as a major part of the response in oligodendrocytes was blocked by tetrodotoxin (TTX), much of the NAAG-evoked current in oligodendrocytes is a secondary consequence of activating neuronal NMDA receptors. Six hours exposure to 1 mM NAAG did not lead to the death of cells in the white matter. We conclude that an action of NAAG on oligodendrocyte NMDA receptors is unlikely to be a major contributor to white matter damage in the leucodystrophies. Keywords: leucodystrophy; Pelizaeus-Merzbacher-like disease; Canavan’s disease; glutamate; NMDA Abbreviations: mGluR3 = metabotropic glutamate receptor 3; NAA = N-acetyl-aspartate; NAAG = N-acetyl-aspartyl-glutamate; NMDA = N-methyl-D-aspartate; TTX = tetrodotoxin Received October 8, 2008. Revised February 11, 2009. Accepted March 2, 2009. Advance Access publication April 21, 2009 ß 2009 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/ 2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. NAAG, NAA and oligodendrocytes Brain 2009: 132; 1496–1508 | 1497 Introduction NAA can be exported to oligodendrocytes, where it is metabolized by the enzyme aspartoacylase, to form acetyl-CoA, which has The speeding of axon potential propagation which is produced by been suggested to be used for myelination (Chakraborty et al., myelination of axons by oligodendrocytes is essential for normal 2001), although this idea has been criticized (Baslow, 2007) on brain function (Fields, 2008). Failure of the development of the grounds that NAA turns over much faster than myelin, myelination, as occurs in genetic leucodystrophies and cerebral and that myelin is still formed in a disorder in which NAA is no palsy, or destruction of myelin, as occurs in multiple sclerosis, longer made. NAAG is broken down to NAA and glutamate by produces mental and physical disability. It has become increasingly glutamatecarboxypeptidases (Berger et al., 1999) located on the clear that activation of glutamate receptors on oligodendrocytes, surface of astrocytes (Fig. 1). or their precursor cells, can lead to loss of myelin. Periventricular In two leucodystrophies there is a defect in the metabolism of leucomalacia, leading to cerebral palsy, can be caused by a NAAG and NAA, associated with a lack of formation of myelin. deficient blood flow to the periventricular white matter and/or Canavan’s disease is caused by a lack of aspartoacylase activity infection, leading to glutamate release that kills precursor and (Fig. 1) in oligodendrocytes (Kumar et al., 2006), which reduces immature oligodendrocytes (Follett et al., 2000; Ka´ rado´ ttir et al., NAA breakdown and thus causes a large rise in NAA and NAAG 2008; Khwaja and Volpe, 2008). In spinal cord injury, secondary levels. Patients have also been reported with a Pelizaeus- ischaemia leads to a release of glutamate by reversed uptake from Merzbacher-like syndrome, in which there is an absence of axons and from oligodendrocytes themselves, which damages myelin similar to that seen when the myelin proteolipid protein oligodendrocytes by activating AMPA/kainate receptors (Li et al., is mutated in Pelizaeus-Merzbacher disease (although no mutation 1999). Oligodendrocytes also express N-methyl-D-aspartate was found in these patients), and this is associated with a large (NMDA) receptors, however, and activation of these receptors by rise of NAAG concentration (Wolf et al., 2008). Because NAA and glutamate released in ischaemia causes demyelination and loss NAAG levels rise in these disorders, and because these agents of axonal action potential propagation (Ka´rado´ ttir et al., 2005; affect neuronal NMDA receptors, we hypothesized that the demyelination occurring in these disorders might reflect NAA Salter and Fern, 2005; Micu et al., 2006; Bakiri et al., 2008). or NAAG acting on oligodendrocyte NMDA receptors. However, Other endogenous molecules may also act on oligodendrocyte the subunit composition of oligodendrocyte NMDA receptors most NMDA receptors. In particular, N-acetyl-aspartate (NAA) and probably differs from that of neuronal ones (Ka´ rado´ ttir et al., N-acetyl-aspartyl-glutamate (NAAG) have been shown to act as 2005; Salter and Fern, 2005; Micu et al., 2006), and so may both agonists and antagonists at neuronal NMDA receptors show a different pharmacological profile. We therefore tested (Westbrook et al., 1986; Sekiguchi et al., 1992; Burlina et al., whether NAAG or NAA can act on oligodendrocyte NMDA 1994; Koenig et al., 1994; Valivullah et al., 1994; Rubin et al., receptors. 1995; Pliss et al., 2000; Bergeron et al., 2005). NAA and NAAG are synthesized in neurons (Baslow, 2007), as shown in Fig. 1. Methods oligodendrocytes aspartate lost in + Preparation Canavan’s acetyl CoA lipids? myelin ? disease Rats (post-natal day 12) were killed by cervical dislocation aspartoacylase in accordance with UK government regulations. Cerebellar slices (225 mm thick) were made in solution containing 124 mM NaCl, 26 mM NaHCO3, 1 mM NaH2PO4, 2.5 mM KCl, 2 mM MgCl2, neurons 2.5 mM CaCl2, 10 mM glucose, bubbled with 95% O2/5% CO2,pH aspartate N-acetylaspartate aspartate N-acetyltransferase NAA L-glutamate ligase 7.4, as well as 1 mM Na-kynurenate to block glutamate receptors. For + + NAAG experiments, slices were superfused at 24 Æ 1C with HEPES-buffered acetyl CoA glutamate solution containing 144 mM NaCl, 2.5 mM KCl, 10 mM HEPES, 1 mM NaH2PO4, 2.5 mM CaCl2, 10 mM glucose, pH set to 7.4 with NaOH, glutamate + NAA NAAG glutamatecarboxypeptidases II and III bubbled with 100% O2. Usually MgCl2 was omitted from the solution, astrocytes and glycine (100 mM, to ensure activation of the glycine site of NMDA receptors) and strychnine (5 mM, to block glycine-gated chloride channels) were added. Some experiments, shown in Figs 9 and 10, Figure 1 Metabolic pathways of NAA and NAAG. NAA is were performed in physiological (1 mM) Mg2+ and with no synthesized in neurons from aspartate and acetyl-CoA. It can added glycine. NAA and NAAG were from Tocris, UK. HPLC data then be exported to oligodendrocytes, where it is converted supplied by Tocris showed that 1 mM NAAG contained 50.2 mM back to acetyl-CoA by aspartoacylase (an enzyme lost in glutamate. Canavan’s disease) and may thus be converted into lipids that form part of the myelin. Alternatively, it can be converted to NAAG in neurons and released to the extracellular space, Electrophysiology where it is converted back to NAA by carboxypeptidases expressed on the extracellular surface of astrocytes. White matter cells (avoiding cerebellar nuclei) were whole-cell clamped with pipettes containing a Cs+-based solution comprising 1498 | Brain 2009: 132; 1496–1508 K. Kolodziejczyk et al. 130 mM Cs-gluconate, 4 mM NaCl, 0.5 mM CaCl2, 10 mM HEPES, 8 h incubation with secondary antibody (goat anti-mouse IgG, 10 mM BAPTA, 4 mM MgATP, 0.5 mM Na2GTP, K-Lucifer yellow 2, AlexaFluor 488, Invitrogen, 1:200). Slices were washed 3 Â 30 min pH set to 7.3 with CsOH. Membrane potentials were compensated with PBS and mounted on coverslips using a mounting solution for the –14 mV junction potential measured with the electrode in containing DAPI to label nuclei. the extracellular solution (Fenwick et al., 1982). Series resistance was 10–30 MV. Mature oligodendrocytes were identified from their morphology after Lucifer filling, with a small number of cells also Confocal microscopy being labelled after recording for myelin basic protein (as in Ka´ rado´ ttir et al., 2005; Ka´ rado´ ttir and Attwell, 2006). Granule cells Confocal images of slices were taken for the cell death assay using were identified from their position in the granule cell layer, their small excitation and emission wavelengths as follows: DAPI (excitation soma attached to approximately four dendrites and their high input 364 nm, emission 4385 nm), AlexaFluor 488 (excitation 488 nm, emis- resistance (43GV).